Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/β-catenin axis
Mammalian Genome · 2026
DOI: 10.1007/s00335-025-10182-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mammalian Genome, 2026. Verfasst von Lijun Zhi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210004,…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, HSP90 Heat-Shock Proteins, beta Catenin, Lactones. Die Arbeit nennt 37 Literaturangaben. Gefördert von: basic research fund project of the Second People's Hospital of Huai'an City.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210004, Jiangsu Province, China.
- Department of Anesthesiology, The Second People's Hospital of Huai'an (The Affiliated Huai'an Hospital of Xuzhou Medical University), No. 155, Hanzhong Road, Qinhuai District, Huai'an, 223001, Jiangsu Province, China.
- Department of Urology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210004, Jiangsu Province, China. yuanlin47@126.com.
Förderung
- basic research fund project of the Second People's Hospital of Huai'an City
Zitieren
APA
Zhi, L., & Yuan, L. (2026). Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/β-catenin axis. Mammalian Genome. https://doi.org/10.1007/s00335-025-10182-4
Vancouver
Zhi L, Yuan L. Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/β-catenin axis. Mammalian Genome. 2026. doi:10.1007/s00335-025-10182-4
BibTeX
@article{Zhi2026,
author = {Zhi, Lijun and Yuan, Lin},
title = {Alantolactone curbs the malignant progression of bladder cancer partly via the HSP90AB1/LRP5/β-catenin axis},
journal = {Mammalian Genome},
year = {2026},
doi = {10.1007/s00335-025-10182-4}
}
EUVIMED